Sonefpeglutide (HM15912)

Sonefpeglutide · Hanmi Pharmaceutical Company Limited

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Sonefpeglutide (HM15912), covering 2025-04-04 to 2025-12-11. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2 Study to Assess the Safety, PK, and PD of Sonefpeglutide (HM15912) in SBS-IF Subjects [Phase 2]